Specific detection system, kit and detection method for semicarbazide sensitive amine oxidase
Through the cysteamine-modified gold nanoparticle probe, the rapid and accurate detection of aminourea-sensitive amine oxidase is achieved by changing the absorbance ratio, which solves the problems of complex detection methods, high cost and poor selectivity in the prior art, and is suitable for large-scale Batch sample analysis.
Patent Information
- Application Number
- CN202410981411.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-11-12
AI Technical Summary
The existing detection methods of aminourea-sensitive amine oxidase are complex in operation, high in cost, poor in selectivity, and are not suitable for large-scale sample detection, making it difficult to achieve convenient and accurate analysis.
Using cysteamine-modified gold nanoparticles as probes, the concentration or vitality of aminourea-sensitive amine oxidase is specifically identified and detected by detecting the absorption ratio changes of the gold nanoparticles, and the concentration or vitality of the aminourea-sensitive amine oxidase is used to use simple colorimetric methods and absorbance changes. Achieve fast and accurate detection.
It realizes simple, fast, low-cost, and strong specificity detection of aminourea-sensitive amine oxidase, which has a short operating time and high sensitivity. It is suitable for large-scale sample detection and does not respond to other amine oxidases.
Smart Images

Figure CN118932013A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of enzyme specific detection, and in particular relates to a semicarbazide-sensitive amine oxidase specific detection system, a kit and a detection method. Background Art
[0002] Semicarbazide Sensitive Amine Oxidase (SSAO), commonly known as vascular adhesion protein-1 (VAP-1), is an amine oxidase that is highly sensitive to semicarbazide. It exists in the form of dimers and is distributed in various tissues of microorganisms, plants and mammals. In mammals, SSAO exists in two forms: one is plasma-soluble, that is, it is soluble in the blood; the other is membrane-bound, that is, it exists in the form of membrane protein in adipose tissue and vascular system. SSAO has multiple physiological functions. In mammals, the role of SSAO in catalyzing the oxidation of amino groups is an indispensable part of the body's metabolism, but its metabolites are all cytotoxic. If the activity of SSAO / VAP-1 is too high and too many toxic products are produced, it will lead to various diseases. For example, methylamine present in urine, blood and tissues is catalyzed and oxidized by SSAO / VAP-1, a key enzyme in its metabolism. The generated formaldehyde will form cross-links with proteins, DNA, etc. in the cell in a covalent manner, leading to changes in cell structure and function, and promoting the formation of advanced glycation end products (AGEs) and advanced fat oxidation end products (ALE), thereby causing the occurrence of related diseases such as diabetes. In addition, SSAO is also closely related to other diseases, including atherosclerosis, inflammatory response, Alzheimer's disease and Parkinson's disease, and is expected to serve as a biomarker for related diseases.
[0003] At present, the detection methods of aminourea-sensitive amine oxidase are mainly divided into chromatography and immunoassay. Enzyme-linked immunosorbent assay kits are commonly used in laboratory testing, but these methods have more or less some limitations, such as complex and time-consuming operations and high costs; the development cost of antibodies with high affinity is high; the selectivity is poor and is not suitable for the detection of large quantities of samples.
[0004] In summary, in order to conduct more convenient and accurate analysis of SSAO in relevant disease pathology research and clinical samples, it is necessary to develop a simple, fast, low-cost and accurate SSAO determination method. Summary of the invention
[0005] The purpose of the present invention is to provide a semicarbazide-sensitive amine oxidase-specific detection system, a kit and a detection method. The method is simple, rapid, low-cost and specific and accurate. The semicarbazide-sensitive amine oxidase can specifically identify gold nanoparticles oxidized with cysteamine (SSAO-specific reaction substrate), and the concentration or activity of the semicarbazide-sensitive amine oxidase is detected by detecting the change in the absorbance ratio of the gold nanoparticles.
[0006] To achieve the above object, the present invention adopts the following technical solutions:
[0007] A semicarbazide-sensitive amine oxidase-specific detection system comprises: cysteamine-modified gold nanoparticles and a semicarbazide-sensitive amine oxidase standard solution.
[0008] The preparation method of the cysteamine-modified gold nanoparticles comprises:
[0009] 1) Add cysteamine to the chloroauric acid solution and stir evenly;
[0010] 2) Add sodium borohydride to the solution and stir vigorously at room temperature in the dark;
[0011] 3) The reaction solution was allowed to stand at room temperature in the dark until the solution changed from yellow to purple-red, indicating the end of the reaction;
[0012] 4) dialyzing the obtained cysteamine-modified gold nanoparticle solution to remove excess chloroauric acid and cysteamine.
[0013] The hydrated particle size of the cysteamine-modified gold nanoparticles is 30-40 nm, and the Zeta potential is 20-30 mV.
[0014] A semicarbazide-sensitive amine oxidase-specific detection kit comprises the above-mentioned semicarbazide-sensitive amine oxidase-specific detection system.
[0015] A method for specifically detecting semicarbazide-sensitive amine oxidase, the method comprising the following steps:
[0016] 1) Add the semicarbazide-sensitive amine oxidase-specific detection system to the well plate, pipette evenly, and incubate at 37°C;
[0017] 2) Detect the absorbance at 522nm and 670nm respectively and analyze the absorbance A 670 / A 522 The ratio of the change in the concentration or activity of semicarbazide-sensitive amine oxidase is taken as the horizontal axis, and the absorbance A 670 / A 522 The ratio is used as the ordinate to establish a standard curve;
[0018] 3) Mix the sample to be tested with cysteamine-modified gold nanoparticles and incubate them, detect the absorbance at 522nm and 670nm, and analyze the absorbance A 670 / A 522 The ratio can be used to obtain the content or enzyme activity of semicarbazide-sensitive amine oxidase in the sample to be tested according to the above standard curve.
[0019] The detection principle of the present invention is that small molecules of cysteamine with primary amine groups can be recognized by SSAO, while monoamine oxidase does not react, and the sulfhydryl group can form a stable gold-sulfur bond with gold, and the synthesized cysteamine-modified gold nanoparticles are used as recognition probes to specifically detect semicarbazide-sensitive amine oxidase.
[0020] Semicarbazide-sensitive amine oxidase can specifically recognize and oxidize cysteamine on the surface of gold nanoparticles to generate aldehydes, which leads to changes in the potential on the surface of gold nanoparticles and subsequent aggregation. Due to the optical properties of gold nanoparticles, the change from a stable monodisperse state to an aggregated state will not only cause a change in the color of the solution, i.e., a change from purple-red to blue-gray; but also the absorption spectrum of the gold nanoparticle solution will change, with a decrease in its maximum ultraviolet absorption value and a red-shifted absorption peak. SSAO can be detected by calculating the absorbance ratio of the two. The higher the content or enzyme activity of semicarbazide-sensitive amine oxidase in the sample to be tested, the greater the aggregation of gold nanoparticles, the more obvious the color change of the reaction solution, and the greater the change in absorbance. Semicarbazide-sensitive amine oxidase can be simply and quickly quantitatively detected by visualizing the changes in colorimetry and absorbance.
[0021] The detection probe system of the present invention uses cysteamine-modified gold nanoparticles as probes, which are specifically recognized and oxidized by semicarbazide-sensitive amine oxidase, and the primary amino group is oxidized to an aldehyde group. After the reaction between the two, the surface potential of the gold nanoparticles changes and the monodisperse state of the colloidal gold solution is destroyed, so that aggregation occurs. The characteristic absorption intensity change can be observed from the absorption spectrum, and a red-shifted absorption peak is generated at the same time, so that quantitative analysis can be performed through the change in the absorption value ratio at different wavelengths to achieve the activity detection of semicarbazide-sensitive amine oxidase.
[0022] In addition, the detection probe selects the recognition group of cysteamine, which has high selectivity for semicarbazide-sensitive amine oxidase, but does not respond to other amine oxidases such as monoamine oxidase.
[0023] The invention is simple, fast and low in cost, and only requires common instruments such as an enzyme marker to accurately and specifically determine the content or enzyme activity of semicarbazide-sensitive amine oxidase, thereby providing a technical solution option for rapid detection of semicarbazide-sensitive amine oxidase in biological or clinical pathological samples. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1It is the reaction principle diagram of the present invention;
[0025] Figure 2 The UV absorption spectrum and color change of cysteamine-modified gold nanoparticles (AuNPs@Cyst) after reacting with semicarbazide-sensitive amine oxidase;
[0026] Figure 3 is the mass spectrum before and after the reaction of cysteamine and SSAO. Figure 3 A is the mass spectrum of cysteamine, Figure 3 B is the mass spectrum after the reaction of cysteamine and SSAO;
[0027] Figure 4 3D simulation diagram of molecular docking of cysteamine with SSAO, MAO-A and MAO-B;
[0028] Figure 5 The UV absorption spectrum and color of cysteamine-modified gold nanoparticles (AuNPs@Cyst);
[0029] Figure 6 Transmission electron microscopy distribution of cysteamine-modified gold nanoparticles (AuNPs@Cyst);
[0030] Figure 7 Transmission electron microscopy distribution of cysteamine-modified gold nanoparticles (AuNPs@Cyst) after reaction with semicarbazide-sensitive amine oxidase;
[0031] Figure 8 The UV absorption spectrum and color change of cysteamine-modified gold nanoparticles (AuNPs@Cyst) after reacting with semicarbazide-sensitive amine oxidase;
[0032] Fig. 9 A is the reaction of cysteamine-modified gold nanoparticles (AuNPs@Cyst) with different concentrations of semicarbazide-sensitive amine oxidase standard solution. 670 / A 522 change;
[0033] Fig.10 The kinetic test results of the reaction between cysteamine-modified gold nanoparticles (AuNPs@Cyst) and semicarbazide-sensitive amine oxidase;
[0034] Fig.11 The specificity test results of cysteamine-modified gold nanoparticles (AuNPs@Cyst);
[0035] Fig.12 A is the reaction of cysteamine-modified gold nanoparticles (AuNPs@Cyst) with a lower concentration of semicarbazide-sensitive amine oxidase standard solution. 670 / A 522 change;
[0036] Fig.13 These are the test results of the gold nanoprobe kit and the human semicarbazide-sensitive amine oxidase activity detection kit (ELISA) of the present invention. DETAILED DESCRIPTION
[0037] The technical solution of the present invention is described in detail below with reference to the accompanying drawings and embodiments.
[0038] like Figure 1 As shown, cysteamine reacts with SSAO to generate mercaptoacetaldehyde with a molecular weight of 76. Due to the optical properties of gold nanoparticles, the change from a stable monodisperse state to an aggregated state will not only cause a change in the color of the solution, that is, a change from purple-red to blue-gray; but also the absorption spectrum of the gold nanoparticle solution will change, its maximum ultraviolet absorption value will decrease, and a red-shifted absorption peak will be generated. SSAO can be detected by calculating the absorbance ratio of the two, as shown in Figure 2 As shown. Cysteamine (Cyst), an aliphatic amine substance that can better bind to semicarbazide-sensitive amine oxidase, was selected as a specific substrate, and the feasibility of cysteamine as a substrate was determined by mass spectrometry, as shown in Figure 3 shown.
[0039] The molecular simulation docking calculations performed by Discovery Studio software revealed that the binding energy of cysteamine to semicarbazide-sensitive amine oxidase SSAO is -27.14 kcal / mol, which is larger than that of monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). Figure 4 As shown, Figure 4 In the middle, the left picture is a 3D simulation diagram of the molecular docking of cysteamine and SSAO, the middle picture is a 3D simulation diagram of the molecular docking of cysteamine and MAO-A, and the right picture is a 3D simulation diagram of the molecular docking of cysteamine and MAO-B.
[0040] A method for preparing cysteamine-modified gold nanoparticles (AuNPs@Cyst) comprises the following synthesis steps:
[0041] 1) Add 100 μL of cysteamine solution (220 mM) to 20 mL of chloroauric acid solution (1.5 mM) and stir at 35°C in the dark for 20 minutes;
[0042] 2) Add 10 μL of sodium borohydride solution (10 mM) to the reaction solution and stir at 35°C in the dark for 30 minutes;
[0043] 3) The reaction solution was allowed to stand at room temperature in the dark for 12 hours to obtain a purple-red solution (AuNPs@Cyst), whose ultraviolet absorption spectrum showed a characteristic absorption peak at 522 nm, such as Figure 5 As shown; AuNPs@Cyst is evenly distributed under transmission electron microscopy, as shown Figure 6 As shown;
[0044] 4) The obtained AuNPs@Cyst solution was dialyzed in a 3.5 kDa dialysis bag overnight to remove excess chloroauric acid and cysteamine.
[0045] The sodium borohydride solution in the present invention is freshly prepared.
[0046] The particle size distribution of the AuNPs@Cyst in the present invention is about 36 nm. The Zeta potential of the AuNPs@Cyst is about 26 mV.
[0047] The kit developed based on this AuNPs@Cyst probe uses the principle of colorimetry. This gold nanoparticle kit capable of rapidly detecting semicarbazide-sensitive amine oxidase includes a gold nanoparticle solution and a standard solution of semicarbazide-sensitive amine oxidase;
[0048] The gold nanoparticle solution is a dialyzed AuNPs@Cyst solution, the purpose of which is to obtain a relatively pure AuNPs@Cyst solution without cysteamine interfering with the test results;
[0049] The kit also includes a detection reaction plate, which is a 96-well transparent cell culture plate.
[0050] The concentration range of the standard solution of semicarbazide-sensitive amine oxidase is 0 to 500 ng / mL.
[0051] The present invention provides a method for detecting semicarbazide-sensitive amine oxidase, comprising the following steps:
[0052] 1) Add gold nanoprobe solution and different concentrations of semicarbazide-sensitive amine oxidase standard solution to a 96-well plate, pipette evenly, and incubate at 37°C for 5 minutes. When the primary amino groups on the surface of the gold nanoparticles are oxidized to aldehyde groups by SSAO, the gold nanoparticles will change from a monodisperse state to an aggregated state. The state change can be observed under a transmission electron microscope, such as Figure 7 As shown in the figure, when the concentration of SSAO increases, the gold nanoparticles aggregate more violently, the color of the solution changes from purple-red to blue-gray, the characteristic absorption peak at 522nm in the ultraviolet absorption spectrum gradually decreases, and a new absorption peak is generated at 670nm, as shown in the figure. Figure 8 shown.
[0053] 2) Use a UV spectrophotometer or microplate reader to measure the absorbance at 522nm and 670nm respectively, and analyze the absorbance A 670 / A 522 The ratio of the concentration of semicarbazide-sensitive amine oxidase is taken as the horizontal axis, and the absorbance A670 / A 522 The ratio is used as the ordinate to establish a standard curve, such as Fig. 9 shown.
[0054] 3) Mix the sample to be tested with the AuNPs@Cyst probe and incubate for 5 min, detect the absorbance at 522 nm and 670 nm, and analyze the absorbance A 670 / A 522 The ratio can be used to calculate the content of semicarbazide-sensitive amine oxidase SSAO in the sample to be tested according to the above standard curve, which can also be regarded as the enzyme activity of SSAO.
[0055] In the above steps, the ratio of the gold nanoprobe solution, the semicarbazide-sensitive amine oxidase standard solution and the sample to be tested is: 190-199 μL of gold nanoprobe solution, 1-10 μL of semicarbazide-sensitive amine oxidase standard solution, and 1-10 μL of the sample to be tested.
[0056] The technical advantages of the present invention are as follows:
[0057] 1) Strong specificity; the present invention determines that cysteamine can be used as a substrate for semicarbazide-sensitive amine oxidase, and that cysteamine has a stronger ability to bind to semicarbazide-sensitive amine oxidase. Figure 3 and Figure 4 )
[0058] 2) Short detection time: through kinetic experiments, it was found that the detection system can obtain results in about 5 minutes ( Fig.10 ). In actual operation, it is only necessary to add the gold nanoprobe and different concentrations of semicarbazide-sensitive amine oxidase standard solutions into the reaction wells, gently blow and mix, incubate at 37°C for 5 minutes, detect the absorbance of the reaction solution, and establish a standard curve; at the same time, replace the semicarbazide-sensitive amine oxidase standard solution with the sample to be tested and repeat the above steps, and the semicarbazide-sensitive amine oxidase concentration or enzyme activity of the sample to be tested can be calculated;
[0059] 3) Through specificity testing, it was determined that the present invention has a stronger specific recognition ability for semicarbazide-sensitive amine oxidase among several amine oxidases ( Fig.11 );
[0060] 3) High detection sensitivity; the detection method of the present invention has a minimum detection limit of less than 0.1 ng / mL ( Fig.12 );
[0061] 4) Large-scale sample detection can be achieved; the present invention uses a 96-well plate as a reaction plate, which can achieve high-throughput screening of multiple samples under the same conditions;
[0062] 5) The amount of sample used is small; the semicarbazide-sensitive amine oxidase standard solution and the sample to be tested required by the present invention only require 1 to 10 μL to achieve accurate detection.
[0063] Example 1 Application of the kit for detecting SSAO content in serum of Parkinson's patients
[0064] The blood of healthy people and Parkinson's patients was centrifuged at 3000 rpm for 10 minutes to obtain serum samples for subsequent testing.
[0065] The above kit and human semicarbazide-sensitive amine oxidase activity detection kit (ELISA, commercially purchased, ELISA company) were used to detect SSAO in serum samples.
[0066] The specific operation steps of the detection kit of the present invention are as follows:
[0067] 1) Add 195 μL of gold nanoprobe solution and 5 μL of different concentrations of semicarbazide-sensitive amine oxidase standard solution to a 96-well plate, pipette evenly, and incubate for 5 minutes;
[0068] 2) Use an ELISA reader to measure the absorbance at 522nm and 670nm respectively and analyze the absorbance A 670 / A 522 The ratio of the concentration of semicarbazide-sensitive amine oxidase is taken as the horizontal axis, and the absorbance A 670 / A 522 The ratio is used as the ordinate to establish a standard curve;
[0069] 3) Mix 5 μL of the serum sample to be tested with 195 μL of the AuNPs@Cyst probe and incubate for 5 min. Detect the absorbance at 522 nm and 670 nm and analyze the absorbance A 670 / A 522 The content of semicarbazide-sensitive amine oxidase SSAO in the sample to be tested can be calculated according to the standard curve.
[0070] The specific operation steps of the human semicarbazide sensitive amine oxidase activity detection kit (ELISA company) are as follows:
[0071] 1) Add 50 μL of different concentrations of semicarbazide-sensitive amine oxidase standard solution into the standard wells;
[0072] 2) Add 10 μL of the serum sample to be tested into the sample well, and then add 40 μL of the sample diluent;
[0073] 3) Add 100 μL of horseradish peroxidase-labeled SSAO antibody to the standard wells and sample wells, seal the reaction wells with a sealing film, and incubate in a 37°C incubator for 60 min;
[0074] 4) Discard the liquid, fill each well with washing solution, let stand for 1 min, discard the liquid, and repeat 5 times;
[0075] 5) Add 50 μL of substrate A and B to each well and incubate at 37°C in the dark for 15 min;
[0076] 6) Add stop solution to each well and detect the absorbance of each well at a wavelength of 450 nm.
[0077] 7) Draw a standard curve and calculate the concentration value of each sample according to the standard curve.
[0078] like Fig.13 As shown (the left figure is the test result of the kit of the present invention, and the right figure is the test result of the human semicarbazide-sensitive amine oxidase activity detection kit), it can be seen from the figure that the significant differences of the two detection methods are consistent, proving the feasibility of the detection method of the present invention.
[0079] The process parameters (such as temperature, time, etc.) of the present invention can realize the method by taking upper and lower limits and interval values, and the embodiments are not listed one by one here.
[0080] Any contents not described in detail in the present invention can be based on the conventional technical knowledge in the art.
[0081] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit the present invention. Although the present invention is described in detail with reference to the embodiments, it should be understood by those skilled in the art that any modification or equivalent replacement of the technical solutions of the present invention does not depart from the spirit and scope of the technical solutions of the present invention and should be included in the scope of the claims of the present invention.
Claims
1. A semicarbazide-sensitive amine oxidase-specific detection system, characterized in that: The detection system comprises: cysteamine-modified gold nanoparticles and a semicarbazide-sensitive amine oxidase standard solution.
2. The semicarbazide-sensitive amine oxidase-specific detection system according to claim 1, characterized in that: The preparation method of the cysteamine-modified gold nanoparticles comprises: 1) Add cysteamine to the chloroauric acid solution and stir evenly; 2) Add sodium borohydride to the solution and stir vigorously at room temperature in the dark; 3) The reaction solution was allowed to stand at room temperature in the dark until the solution changed from yellow to purple-red, indicating the end of the reaction; 4) dialyzing the obtained cysteamine-modified gold nanoparticle solution to remove excess chloroauric acid and cysteamine.
3. The semicarbazide-sensitive amine oxidase-specific detection system according to claim 1, characterized in that: The hydrated particle size of the cysteamine-modified gold nanoparticles is 30-40 nm, and the Zeta potential is 20-30 mV.
4. The semicarbazide-sensitive amine oxidase-specific detection system according to claim 1, characterized in that: The concentration range of the standard solution of semicarbazide-sensitive amine oxidase is 0 to 500 ng / mL.
5. A semicarbazide-sensitive amine oxidase-specific detection kit, characterized in that: The kit comprises the semicarbazide-sensitive amine oxidase-specific detection system according to any one of claims 1 to 4.
6. A method for specifically detecting semicarbazide-sensitive amine oxidase, the method comprising the following steps: 1) Add the semicarbazide-sensitive amine oxidase-specific detection system according to any one of claims 1 to 4 to the well plate, pipette evenly, and incubate at 37° C.; 2) Detect the absorbance at 522nm and 670nm respectively and analyze the absorbance A 670 / A 522 The ratio of the change in the concentration or activity of semicarbazide-sensitive amine oxidase is taken as the horizontal axis, and the absorbance A 670 / A 522 The ratio is used as the ordinate to establish a standard curve; 3) Mix the sample to be tested with cysteamine-modified gold nanoparticles and incubate them, detect the absorbance at 522nm and 670nm, and analyze the absorbance A 670 / A 522 The ratio can be used to obtain the content or enzyme activity of semicarbazide-sensitive amine oxidase in the sample to be tested according to the above standard curve.
